Baker, B., Schaeffler, B., Hirman, J., Hompesch, M., Pederson, S., & Smith, J. (2021, April). Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients. Endocrinology, Diabetes & Metabolism.
Chicago Style (17th ed.) CitationBaker, Brian, Barbara Schaeffler, Joe Hirman, Marcus Hompesch, Susan Pederson, and Jeff Smith. "Tolerability of Eptinezumab in Overweight, Obese or Type 1 Diabetes Patients." Endocrinology, Diabetes & Metabolism Apr. 2021.
MLA (9th ed.) CitationBaker, Brian, et al. "Tolerability of Eptinezumab in Overweight, Obese or Type 1 Diabetes Patients." Endocrinology, Diabetes & Metabolism, Apr. 2021.
Warning: These citations may not always be 100% accurate.
